ALLI

LOE ApproachingSM

orlistat

NDAORALCAPSULE
Approved
Feb 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

Lipase Inhibitors

Pharmacologic Class:

Intestinal Lipase Inhibitor

Clinical Trials (5)

NCT07366424N/ANot Yet Recruiting

Evaluating the Impact of "CHUT OTONOM®" Footwear on the Spatio-temporal Parameters of Walking and the Risk of Falls in Elderly People at High Risk of Falling.

Started Jan 2026
NCT07341152Phase 1Completed

A Study Comparing LTG-001 SDD Formulation To LTG-001 Crystalline Immediate Release Tablets In Healthy Participants

Started Oct 2025
14 enrolled
Pain Management
NCT07129954N/ARecruiting

Fear of Falling in Muscular Dystrophy

Started Jul 2025
100 enrolled
Fear of FallingDuchenne Muscular Dystrophy (DMD)Muscular Dystrophies+1 more
NCT06680622Phase 2Active Not Recruiting

Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy

Started Mar 2025
126 enrolled
Metastatic Gastro-esophageal Adenocarcinoma
NCT06782724Phase 2Not Yet Recruiting

Psilocybin Therapy for Psychological Distress in Palliative Patients

Started Mar 2025
108 enrolled
COPD (Chronic Obstructive Pulmonary Disease)ALS (Amyotrophic Lateral Sclerosis)MS (Multiple Sclerosis)+2 more